Mobility Hypertension Management Study
MHM
1 other identifier
interventional
400
1 country
1
Brief Summary
The present prospective study aims to assess the efficacy of using the telehealth solution "Hypertension Monitor" in patients with hypertension by comparison to the standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 6, 2018
CompletedStudy Start
First participant enrolled
June 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedAugust 9, 2018
August 1, 2018
1.1 years
February 2, 2018
August 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic Blood Pressure (measured in clinic)
Systolic blood pressure will be measured in clinic according to the guidelines of the European Society of Hypertension (ESH).
Primary objective after 3 month
Secondary Outcomes (1)
Timing to reach the blood pressure target
Evaluation performed at Month1 and Month 3
Study Arms (2)
Standard Care
NO INTERVENTIONThis group is the usual standard treatment group
Telemonitoring group
OTHERThis group will followed up with telemonitoring
Interventions
the follow-up of the patient will be performed with Telemonitoring
Eligibility Criteria
You may qualify if:
- Men or women
- Age between 18 and 80 years
- Patients with essential moderate Hypertension
- untreated or not adequately treated (need for treatment changes)
- Given written informed consent
You may not qualify if:
- Severe Hypertension (\>180/110 mmHg)
- Difficulties to perform home blood pressure measurements
- Patients with arm circumference \> 42 cm
- Night shift workers
- Body mass index \> 35 kg/m²
- Atrial fibrillation and/or another arrhythmia
- Pregnancy
- Cardiovascular events (stroke, Myocardial infarction) in the last 6 months
- Severe Sleep Apnea Syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roland Asmar
Paris, 75016, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ROLAND ASMAR, MD
Foundation-Medical research Institutes
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the Data analysis will be performed by an independent team with masking the patients groups
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2018
First Posted
March 6, 2018
Study Start
June 3, 2018
Primary Completion
June 30, 2019
Study Completion
December 30, 2019
Last Updated
August 9, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Study documents: Q1 2018 Study Results: Q2 2019
- Access Criteria
- the request will be reviewed by the scientific committee. Requestors will be required to sign an access agreement
the essential documents and the study results will be shared with all the investigators.